University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 12 of 23
Delineating Swallowing Impairment and Decline in ALS
NCT02962050
Lactate Acidosis in Postoperative Hearts
NCT03025659
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
NCT03112486
The Role of the Space Environment on Vascular Endothelial and Smooth Muscle Cell Processes
NCT03156257
Microgravity Effects on Co-cultured Vascular Cells Types
NCT03144492
Normal Breathing and Swallowing in Healthy Volunteers
NCT03122145
Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation
NCT03114124
Effect of Armodafinil on Simulated Driving
NCT02468856
Topical NanoDox® for Atopic Dermatitis
NCT02910011
Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination
NCT03728608
Parents of Young Adults With Type 1 Diabetes: An Exploratory Study
NCT03158415
Pediatric Obesity and the Infant Microbiome (BEACH)
NCT02843087
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade
NCT03063255
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
NCT03092375
Compassion Fatigue in ED Providers
NCT03070249
Efficacy of Pea Hull Fiber - Phase 2
NCT03016065
Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
NCT03095170
Steroids in Children Hospitalized With Asthma
NCT02780479
Central Mechanisms of Chronic Pain and Fatigue Subtitle: Functional Imaging of Brain and Spinal Cord
NCT03075254
Increasing Uptake of Behavioral Weight Loss Programs Among Primary Care Patients
NCT02708121
The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care
NCT03044691
Sargramostim for Myeloid Dendritic Cell Deficiency
NCT03063242
Ketamine vs Hydromorphone
NCT03001843
Probiotics That Moderate pH and Antagonize Pathogens to Promote Oral Health
NCT02999230
Intermittent Hypoxia and Inspiratory Threshold Loading to Enhance Inspiratory Muscle Function
NCT03029559
Beat AML Core Study
NCT02927106
Citrus Beverages and Gastrointestinal Function
NCT02979496
Nutrition Education in Fellows
NCT03044717
Neural Correlates of Cognition in Parkinson's Disease
NCT02975193
fMRI Connectivity in Fracture Hip Patients
NCT02997930
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
NCT02984436
To Determine the Metabolomics and Microbiome Changes After Cranberry Juice Consumption Among Young Women
NCT02860468
Antibiotic "Dysbiosis" in Preterm Infants
NCT02784821
Management of Uncontrolled Hypertension (HTN)
NCT02922023
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
NCT02663271
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
NCT02773732
Smoking Cessation Intervention
NCT03072511
Blood Flow Restriction Exercise Study
NCT02868021
Effect of Obesity on Immune Response to Pneumovax 23
NCT02471014
Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans
NCT02765672
ARCH II Study (Alcohol Research Center on HIV Study II)
NCT02563574
Image Parkinson's Disease Progression Study
NCT02789020
MenB Vaccine: Implementation Via Information, Empowerment and Accessibility
NCT02975596
Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing
NCT02930824
The Prevention of Hypotension After Epidural Analgesia After Major Surgery
NCT02722746
Pulse Oximetry With Automated Verbal Prompts
NCT02930863
Cardiovascular Health of Older Adults and Resveratrol (CORE)
NCT02909699
Sensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size Distribution
NCT01966692
A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy
NCT02839460
The Efficient Brain Study
NCT02771366
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.